Patent - Abbreviated New Drug Application Cases filed in Delaware
Cases 81 - 90 of 1,147
Celgene Corporation et al v. Natco Pharma Limited
as 1:2023cv01019
Plaintiff: Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant: Natco Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property Gmbh, et al. v. Auson Pharmaceuticals Inc., et al.
as 1:2023cv01103
Counter Defendant: Bayer Intellectual Property GMBH
Plaintiff: Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals Inc.
Defendant: Auson Pharmaceuticals, Inc. and Auson Pharmaceuticals Co., Ltd.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2023cv01015
Plaintiff: Heron Therapeutics, Inc.
Defendant: Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Galderma Laboratories, L.P. et al v. Apotex Inc. et al
as 1:2022cv00724
Plaintiff: Galderma Laboratories, L.P. and TCD Royalty Sub LP
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. Teva Pharmaceuticals, Inc.
as 1:2023cv01008
Plaintiff: Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant: Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amicus Therapeutics US, LLC et al v. Lupin Ltd. et al
as 1:2023cv00964
Counter Defendant: Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Counter Claimant: Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Zenara Pharma Private Limited
as 1:2023cv00924
Plaintiff: Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant: Zenara Pharma Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Aurobindo Pharma Limited
as 1:2023cv00923
Plaintiff: Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant: Aurobindo Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al. We have downloadable decisions or orders for this case
as 1:2019cv01727
Counter Defendant: Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant: MSN Laboratories Private Limited, Alkem Laboratories Limited, Hetero USA Inc. and others
Plaintiff: Eden Biodesign, LLC.
Defendant: Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Fresenius Kabi USA, LLC et al v. Caplin Steriles Ltd. et al
as 1:2023cv01144
Plaintiff: Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GmbH
Defendant: Caplin Steriles Ltd. and Caplin Steriles USA Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?